A potential mechanism for mitral valve prolapse syndrome

Journal of Cardiovascular Electrophysiology

Volumn 9, Issue 1, 1998, Pages 100-102

  Slovut, David P ^b   Lurie, Keith G ^a,c  

^a Cardiovascular Division   (United States)

^b UNIVERSITY OF MINNESOTA   (United States)

^c UNIV OF MINNESOTA HOSP AND CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEART INNERVATION; HEART PALPITATION; HUMAN; MITRAL VALVE; MITRAL VALVE PROLAPSE; PATHOGENESIS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVIEW;

EID: 0031931810     PISSN: 10453873     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1540-8167.1998.tb00872.x     Document Type: Review

References (21)

1. Devereux RB: Recent developments in the diagnosis and management of mitral valve prolapse. Curr Opin Cardiol 1995;10:107-116.
2. Fontana ME, Sparks EA, Boudoulas H, et al: Mitral valve prolapse and the mitral valve prolapse syndrome. Curr Prob Cardiol 1991;16:309-375.
3. Kligfield P, Hochreiter C, Kramer H, et al: Complex arrhythmias in mitral valve regurgitation with and without mitral valve prolapse: Contrast to arrhythmias in mitral valve prolapse without mitral regurgitation. Am J Cardiol 1985;55:1545-1549.
4. Levy S: Arrhythmias in the mitral valve prolapse syndrome: Clinical significance and management. PACE 1992;15:1080-1088.
5. Kavey RE, Blackman MS, Sondheimer HM, et al: Ventricular arrhythmias and mitral valve prolapse in childhood. J Pediatr 1984;105:885-890.
6. Moritz HA, Parnass SM, Mitchell JS: Ventricular fibrillation during anesthetic induction in a child with undiagnosed mitral valve prolapse. Anesth Analg 1997;85:59-61.
7. Boudoulas H, Kolibash AJ, Baker P, et al: Mitral valve prolapse and the mitral valve prolapse syndrome: A diagnostic classification and pathogenesis of symptoms. Am Heart J 1989;118:796-818.
8. Davies AO, Mares A, Pool JL, et al: Mitral valve prolapse with symptoms of beta-adrenergic hypersensitivity. Beta 2-adrenergic receptor supercoupling with desensitization on isoproterenol exposure. Am J Med 1987;82:193-201.
9. Boudoulas H, Reynolds JC, Mazzaferri E, et al: Mitral valve prolapse syndrome: The effect of adrenergic stimulation. J Am Coll Cardiol 1983;2:638-644.
10. Alpert MA, Mukerji V, Sabeti M, et al: Mitral valve prolapse, panic disorder, and chest pain. Med Clin North Am 1991;75:1119-1133.
11. Lurie KG, Benditt D: Syncope and the autonomic nervous system. J Cardiovasc Electrophysiol 1996;7:760-776.
12. Linzer M: Syncope. Am J Med 1991;90:1-5.
13. Boudoulas H, Wooley CF: Mitral valve prolapse syndrome. Evidence of hyperadrenergic state. Postgrad Med 1988;Feb 29:152-162.
14. LeWinter MM, Hoffman JR, Shell WE, et al: Phenylephrine-induced atypical chest pain in patients with prolapsing mitral valve leaflets. Am J Cardiol 1974;34: 12-18.
15. Lurie KG, Dutton J, Wiegn P: Regional distribution of ECS in contractile and conductive elements of rat and rabbit heart. Am J Physiol 1992;263:H168-H176.
16. Marron K, Yacoub MH, Polak JM, et al: Innervation of human atrioventricular and arterial valves. Circulation 1996;94:368-375.
17. Oki T, Fukuda TK, Iuchi A, et al: Histopathologic studies of innervation of normal and prolapsed human mitral valves. J Heart Valve Dis 1995;4:496-502.
18. de la Torre JC, Surgeon JW: A methodological approach to rapid and sensitive monoamine histofluorescence using a modified glyoxylic acid technique: The SPG method. Histochemistry 1976;49: 81-93.
19. Mense S, Hoheisel U, Reinert A: The possible role of substance P in eliciting and modulating deep somatic pain. Prog Brain Res 1996;110:125-135.
20. Payan DG: Neuropeptides and inflammation: The role of substance P. Annu Rev Med 1989;40:341-352.
21. Winkle RA, Lopes MG, Goodman DJ, et al: Propranolol for patients with mitral valve prolapse. Am Heart J 1977;93:422-427.